IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection
Year: 2024
Type: article
Abstract: Dynamic regulation of cellular metabolism is important for maintaining homeostasis and can directly influence immune cell function and differentiation, including NK cell responses. Persistent HIV-1 infection leads to a state of chronic immune activation, NK cell subset redistribution, and progressive NK cell dysregulation. In this study, we examined the metabolic processes that characterize NK cell subsets in HIV-1 infection, including adaptive NK cell subpopulations expressing the activating receptor NKG2C, which expand during chronic infection. These adaptive NK cells exhibit an enhanced metabolic profile in HIV-1- individuals infected with human cytomegalovirus (HCMV). However, the bioenergetic advantage of adaptive CD57+NKG2C+ NK cells is diminished during chronic HIV-1 infection, where NK cells uniformly display reduced oxidative phosphorylation (OXPHOS). Defective OXPHOS was accompanied by increased mitochondrial depolarization, structural alterations, and increased DRP-1 levels promoting fission, suggesting that mitochondrial defects are restricting the metabolic plasticity of NK cell subsets in HIV-1 infection. The metabolic requirement for the NK cell response to receptor stimulation was alleviated upon IL-15 pretreatment, which enhanced mammalian target of rapamycin complex 1 (mTORC1) activity. IL-15 priming enhanced NK cell functionality to anti-CD16 stimulation in HIV-1 infection, representing an effective strategy for pharmacologically boosting NK cell responses.
Source: JCI Insight
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,100
Funders: Wellcome Trust, Kennedy Trust for Rheumatology Research, National Institute for Health and Care Research, Academy of Medical Sciences, Rosetrees Trust, National Institutes of Health, Medical Research Council, National Institute of Allergy and Infectious Diseases, H2020 European Research Council
Awards: G1395085096, G1865113916, G1878121697, G2228582965, G2486546438, G2597692724, Immunological synapse derived ectosomes in T cell effector function, Natural killer cell regulation of the germinal center HIV neutralizing antibody response, G3135863617, G3972472086, Natural Killer (NK) cell regulation of antiviral T cell responses in the pathogenesis of HIV infection, Translation of the immunological synapse., Exploiting Natural Killer cells in HIV/HBV co-infection to achieve eradication, G7233741441, Natural killer cell regulation of the germinal center HIV neutralizing antibody response, G7720689167, G7769511091, G7932577822, G814556379, Natural Killer (NK) cell regulation of antiviral T cell responses in the pathogenesis of HIV infection, Induction of protective antibodies for HIV vaccine development
OpenAlex ID: W4392006291
